Historical Stock Price
DNDN historical stock prices picture
DNDN (DNDN) has the following price history information. Looking back at DNDN historical stock prices for the last five trading days, on November 12, 2014, DNDN opened at $0.15, traded as high as $0.18 and as low as $0.15, and closed at $0.16. Trading volume was a total of 17.19M shares. On November 13, 2014, DNDN opened at $0.16, traded as high as $0.17 and as low as $0.12, and closed at $0.13. Trading volume was a total of 18.66M shares. On November 14, 2014, DNDN opened at $0.12, traded as high as $0.13 and as low as $0.11, and closed at $0.11. Trading volume was a total of 13.20M shares. On November 17, 2014, DNDN opened at $0.11, traded as high as $0.17 and as low as $0.11, and closed at $0.15. Trading volume was a total of 26.47M shares. On November 18, 2014, DNDN opened at $0.16, traded as high as $0.17 and as low as $0.13, and closed at $0.13. Trading volume was a total of 22.73M shares.

DNDN Historical Stock Prices By Date:

DNDN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into DNDN shares, starting with a $10,000 purchase of DNDN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 11/18/2014
Start price/share: $3.00
End price/share: $0.13
Dividends collected/share: $0.00
Total return: -95.67%
Annualized Gain: -151.16%
Starting investment: $10,000.00
Ending investment: $433.00
Years: 0.63
Date Open High Low Close Volume
11/12/2014 $0.15 $0.18 $0.15 $0.16 17.19M
11/13/2014 $0.16 $0.17 $0.12 $0.13 18.66M
11/14/2014 $0.12 $0.13 $0.11 $0.11 13.20M
11/17/2014 $0.11 $0.17 $0.11 $0.15 26.47M
11/18/2014 $0.16 $0.17 $0.13 $0.13 22.73M
Dendreon is a biotechnology company focused on the discovery, development and commercialization of therapeutics for cancer treatment. PROVENGE® (sipuleucel-T) is Co.'s commercialized product, and is an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic, metastatic, castrate-resistant (hormone-refractory) prostate cancer. Co. owns worldwide rights for PROVENGE. Other product candidates under development include investigational cellular immunotherapies for the treatment of patients with bladder, breast, ovarian and other solid tumors; renal cell carcinoma; and colorectal and other cancers.
Date Close
11/12/2014$0.16
11/13/2014$0.13
11/14/2014$0.11
11/17/2014$0.15
11/18/2014$0.13
DNDN is categorized under the Healthcare sector; below are some other companies in the same sector:

DOVA Historical Stock Prices
DPLO Historical Stock Prices
DPRX Historical Stock Prices
DR Historical Stock Prices
DRAD Historical Stock Prices
DRIO Historical Stock Prices
DRNA Historical Stock Prices
DRRX Historical Stock Prices
DRTX Historical Stock Prices
DSCI Historical Stock Prices

Email EnvelopeFree DNDN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


DNDN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.